Neurology
RSSArticles
-
Recombinant Activated Factor VIIa: Phase III Trial Fails to Show Clinical Benefit
Even though rFVIIa reduced hematoma growth, it did not reduce mortality in patients with ICH. -
Clinical Briefs in Primary Care supplement
-
Full July 1, 2008 Issue in PDF
-
Everything in Moderation, Including Sleep
Both short (6 or fewer hours) and long (9 or more hours) habitual sleep durations predict an increased risk of weight gain in adults. -
Should Women Quit Smoking Now or Wait?
Early age at initiation of smoking is associated with an increased mortality risk in women. Quitting reduces the excess mortality risk for all major causes of smoking related deaths. -
Alvimopan Capsules (Entereg®)
The FDA has approved a drug to help patients regain bowel function following bowel resection surgery. -
Clinical Briefs by Louis Kuritzky, MD
Vasculopathy knows no compartmentalization. Clinicians expect that patients with peripheral arterial disease will also commonly have comorbid coronary or cerebrovascular disease, even though it may be silent. -
The Risks of Abdominal Obesity
Data from the Nurses Health Study revealed that abdominal obesity in females is significantly and positively associated with all-cause and cause-specific mortality and specifically is associated with increased CVD mortality even in normal-weight women. -
Full June 29, 2008 Issue in PDF
-
Regadenoson Injection (Lexiscan™)
Regadenoson, the first selective A2A adenosine receptor agonist, has been approved for use as a pharmacologic stress agent for nuclear medicine stress testing (radionuclide myocardial perfusion imaging).